Aratana Therapeutics, Inc.
(NASDAQ : PETX)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.08%178.890.7%$1150.86m
LLYEli Lilly & Co. 1.17%374.681.1%$1117.28m
MRKMerck & Co., Inc. 0.22%110.040.7%$1021.82m
PFEPfizer Inc. -0.37%50.890.9%$965.33m
ABBVAbbVie, Inc. 1.24%163.641.9%$868.91m
BMYBristol-Myers Squibb Co. 0.27%81.101.1%$765.35m
AZNAstraZeneca Plc 0.19%68.471.0%$350.56m
HZNPHorizon Therapeutics Plc 3.94%104.855.4%$310.89m
IDXXIDEXX Laboratories, Inc. -0.88%435.303.9%$216.72m
CTLTCatalent, Inc. 0.13%52.301.9%$206.27m
GSKGSK Plc 0.89%35.340.3%$187.83m
NVSNovartis AG 0.15%89.950.2%$184.65m
ALNYAlnylam Pharmaceuticals, Inc. 6.43%234.408.0%$174.69m
NVONovo Nordisk A/S 0.62%126.910.1%$165.68m
SRPTSarepta Therapeutics, Inc. 2.66%126.2512.4%$128.59m

Company Profile

Aratana is uniquely positioned to deliver new, high-quality medicines to address unmet needs in companion animal care. We are committed to bringing world class science to animal health for companion animals and the people who care for them. Our competitive advantage resides in our ability to identify, acquire and develop high-value commercial products for companion animals in a cost effective and efficient manner.